ArticleJournal of oncology2022

A Three-Gene Signature for Predicting the Prognosis of Patients Treated with Transarterial Chemoembolization (TACE) and Identification of PD-184352 as a Potential Drug to Reverse Nonresponse to TACE.

Zicong Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.